Reducing Animal Testing Act

Bill: 117-s-4288
Sponsor: full_name: Sen. Lujan, Ben Ray [D-NM]
Introduced: 2022-05-19
Policy area: Health
Latest action: action_date: 2022-05-19
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2022-05-19
action_desc: Introduced in Senate
text: <p><b>Reducing Animal Testing Act</b></p> <p>This bill removes animal studies as a required component of biosimilar applications and instead allows applicants to use other types of studies to assess toxicity.</p>

tv_txt: II 117th CONGRESS 2d Session S. 4288 IN THE SENATE OF THE UNITED STATES May 19 (legislative day, May 17), 2022 Mr. Luján introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a biological product.

1. Short title This Act may be cited as the Reducing Animal Testing Act . 2. New approach methodologies Item (bb) of section 351(k)(2)(A)(i)(I) of the Public Health Service Act ( 42 U.S.C. 262(k)(2)(A)(i)(I) ) is amended to read as follows: (bb) an assessment of toxicity (which may rely on, or consist of, a study or studies described in item (aa) or (cc)); and .